Replies to post #496449 on NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

Thanks for sharing BSB. As more and more trials fail in expanded indications, clearly Merck needs us to continue to retain its Keytruda revenue as Keytruda patent expires in 5 yrs. Liau showed DcVaxL combo with Keytruda and PCLYC TLR agonist effectively eliminates even hard to treat resistant GBM tumors. Merck should partner with us or buy us out, imo. What is Merck waiting for?